Latest & greatest articles for stroke

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on stroke or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on stroke and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for stroke

1. Covid-19: Stroke

, stroke patients are advised to protect themselves from contagion, given they are at increased risk for complications if they get COVID-19. Moreover, based on current information, it appears that elderly people with coronary heart disease or hypertension are more likely to present with more severe symptoms. People affected by infectious diseases as COVID-19 are also at increased risk of ischaemic and haemorrhagic cerebrovascular complications. For this reason, an increased number of strokes could (...) be forecast. However, an unexpected reduction of stroke patients in the emergency room throughout Europe has been observed. It is reasonable to assume that patients with acute mild stroke or TIA remain at home, because they are asked to stay at home, limit emergency room visits, and minimise travel. The patients may be prioritising avoiding contagion. Another issue is that stroke care organization and pathways within hospitals are currently adapted to cover the requirements of dealing with COVID-19

2020 European Academy of Neurology

2. Prevalence of dysphagia and economic burden of aspiration pneumonia in patients with stroke or head and neck cancer

Prevalence of dysphagia and economic burden of aspiration pneumonia in patients with stroke or head and neck cancer application/octet-stream

2020 Institute of Health Economics

3. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke

found: AHI >5 in 70.4% (95% CI 62.1%–78.7%), AHI >20 in 39.5% (95% CI 31.6%–47.4%), and AHI >30 in 30.1% (95% CI 23.1%–37.0%) (Table S11). The meta-analysis by Seiler et al. [109] included a total of 89 studies where at least 10 patients were assessed, and full PSG or a portable device was used for diagnosis (Table S11). Fifty-four studies assessed patients 3 months after stroke. The distribution of stroke types was as follows: ischaemic stroke 5275, haemorrhagic stroke 302, TIA 405, unde?ned 1188 (...) cerebrovascular events. Does treatment of SDB have any impact on mortality and outcome after stroke? Whilst SDB and, in particular, OSA is common in stroke patients and associated with an increased risk of recurrent stroke and all-cause mortality, the impact of treating SDB on neurological recovery and cardio- vascular morbidity and mortality has only recently been explored. Results of the literature search. • The search revealed two updated systematic reviews with meta-analyses using CPAP or non-invasive

2020 European Academy of Neurology

4. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke

Institute, Cumming School of Medicine, University of Calgary, AB, Canada (S.B.C., M.D.H.). 6 University of Montreal, QC, Canada (L.C.G). PMID: 32098609 DOI: Item in Clipboard Full-text links Cite Abstract Background and Purpose- Patients with transient ischemic attack (TIA) and minor ischemic stroke are at risk for early recurrent cerebral ischemia. Anticoagulants are associated with reduced recurrence but also increased hemorrhagic transformation (HT). The safety of the novel oral anticoagulant (...) dabigatran in acute stroke has not been evaluated. Methods- DATAS II (Dabigatran Treatment of Acute Stroke II) was a phase II prospective, randomized open label, blinded end point trial. Patients with noncardioembolic stroke/transient ischemic attack (National Institutes of Health Stroke Scale score, ≤9; infarct volume, ≤25 mL) were randomized to dabigatran or aspirin. Magnetic resonance imaging was performed before randomization and repeated at day 30. Imaging end points were ascertained centrally

2020 EvidenceUpdates

5. Timing of procedural stroke and death in asymptomatic patients undergoing carotid endarterectomy: individual patient analysis from four RCTs Full Text available with Trip Pro

complications (18 fatal strokes, 68 non-fatal strokes, 11 fatal myocardial infarctions and 6 deaths from other causes) [Correction added on 20 April, after first online publication: the percentage value has been corrected to 2·8]. Of the 86 strokes, 67 (78 per cent) were ipsilateral, 17 (20 per cent) were contralateral and two (2 per cent) were vertebrobasilar. Forty-five strokes (52 per cent) were ischaemic, nine (10 per cent) haemorrhagic, and stroke subtype was not determined in 32 patients (37 per cent (...) Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK. 3 Department of Vascular Surgery, University Medical Centre, Utrecht, the Netherlands. 4 Centre for Prevention of Stroke and Dementia, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. 5 Department of Neurology and Neurosurgery, UMC Utrecht Brain Centre, Utrecht, the Netherlands. 6 Julius Centre for Health Sciences and Primary Care, Utrecht University, Utrecht, the Netherlands. 7

2020 EvidenceUpdates

6. Practice advisory update: Patent foramen ovale and secondary stroke prevention

in patients with cerebrovascular disease, and patent foramen ovale (PFO) and stroke; has received support from WL Gore and Associates for the REDUCE PFO closure study, from GlaxoSmithKline for a study of outcomes from proximal aortic surgeries, from Bayer for a study of rivaroxaban for secondary stroke prevention in patients with embolic stroke of undetermined source, from Mallinkrodt for a study of the impact of inhaled nitric oxide on cerebral perfusion, from Novartis for a study of BAF312 in patients (...) with intracerebral hemorrhage (ICH), from Biogen for a study of glibenclamide for cerebral edema following large hemispheric infarction; and received support from the National Institutes of Health (NIH) for work with the cardiothoracic surgery network, deferoxamine in ICH, neurologic outcomes in a renal insufficiency cohort; and has provided his expert opinion for medical-legal cases involving stroke. G. Gronseth serves as an associate editor for Neurology; has served as chief evidence-based medicine consultant

2020 American Academy of Neurology

7. Association of CHA2 DS2 -VASc Score with Stroke, Thromboembolism, and Death in Hip Fracture Patients

, Denmark. 3 Department of Geriatrics, Aarhus University Hospital, Aarhus, Denmark. PMID: 32294240 DOI: Item in Clipboard Full-text links Cite Abstract Objectives: Patients undergoing hip fracture surgery have a 10 times increased risk of stroke compared with the general population. We aimed to evaluate the association between the CHA 2 DS 2 -VASc (congestive heart failure, hypertension, age ≥75 years, diabetes, previous stroke/TIA [transient ischemic attack]/systemic embolism (2 points), vascular (...) Registry. Measurements: We calculated incidence rates, cumulative incidences, and hazard ratios (HRs) with 95% confidence intervals (CIs) by CHA 2 DS 2 -VASc score, stratified on AF history. Results: The cumulative incidence of ischemic stroke 1 year after hip fracture increased with ascending CHA 2 DS 2 -VASc score, and it was 1.9% for patients with a score of 1 and 8.6% for patients with a score above 5 in the AF group. Corresponding incidences in the non-AF group were 1.6% and 7.6%. Compared

2020 EvidenceUpdates

8. Canadian Stroke Best Practice recommendations, seventh edition: acetylsalicylic acid for prevention of vascular events

on antiplatelet and anticoagulant use, 9 and Thrombosis Canada clinical guides. 8GUIDELINE E304 CMAJ | MARCH 23, 2020 | VOLUME 192 | ISSUE 12 of placebo reduced the number of serious vascular events by 36 (standard error [SE] 5) per 1000 per year in patients with a previ- ous myocardial infarction and also by 36 (SE 6) per 1000 per year in patients with a previous history of stroke or transient ischemic attack. In patients with peripheral arterial disease, treatment with ASA instead of placebo reduced (...) outcome were 0.96 (95% confidence interval [CI] 0.81–1.13) and 0.95 (95% CI 0.83–1.08), respectively. In the ASCEND trial, 4 the risk of the primary outcome (first serious vascular event [myocardial infarction, stroke, transient ischemic attack or cardiovascular death]) was significantly lower in the ASA group (8.5% v. 9.6%; relative risk [RR] 0.88, 95% CI 0.79–0.97). The results of these 3 trials were incorporated into 2 system- atic reviews, the results of which conflicted. 5,6 The use of ASA did

2020 CPG Infobase

9. Temporary Emergency Guidance to U.S. Stroke Centers During the COVID-19 Pandemic Full Text available with Trip Pro

Pandemic On Behalf of the AHA/ASA Stroke Council Leadership and On Behalf of the AHA/ASA Stroke Council Leadership Originally published 1 Apr 2020 Stroke. ;0:null Abstract During this unprecedented time of extraordinary stress on the US healthcare system, the AHA/ASA Stroke Council—as individuals in our localities and together as an entity at the national level—acknowledge the mounting concern regarding optimal stroke care during the COVID-19 pandemic among vascular neurologists and those clinicians (...) Temporary Emergency Guidance to U.S. Stroke Centers During the COVID-19 Pandemic Temporary Emergency Guidance to US Stroke Centers During the COVID-19 Pandemic | Stroke Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Temporary Emergency Guidance to US Stroke Centers During the COVID-19

2020 American Heart Association

10. Continual Long-Term Physiotherapy After Stroke

are eligible to receive continual long-term community-based physiotherapy have already received 12 weeks of physiotherapy after being diagnosed with stroke. We excluded people who were admitted to hospital for transient ischemic attack, as it is characterized as a minor and nondisabling type of stroke, 16 and focused on people who were admitted for either ischemic or (intracerebral or subarachnoid) hemorrhagic stroke. Budget Impact Analysis March 2020 Ontario Health Technology Assessment Series; Vol. 20 (...) and long-term medical attention. There are different types of stroke. The two major classifications are ischemic stroke and hemorrhagic stroke. Ischemic stroke occurs when an artery in the brain is blocked. Hemorrhagic stroke occurs when a blood vessel in the brain breaks open, interrupting blood flow in the brain. 1 Clinical Need and Target Population In Canada, approximately 62,000 people suffer a stroke annually, and about 405,000 are living with the consequences of a stroke. 2 This number

2020 Health Quality Ontario

11. Canadian Stroke Best Practice recommendations: rehabilitation, recovery, and community participation following stroke. Part one: rehabilitation and recovery following stroke; 6th edition update 2019

be costly, or forgo super- vised therapy and potentially not meet their rehabilita- tion and recovery potential. The 2019 update of the Canadian Stroke Best Practice Recommendations (CSBPR): Rehabilitation and Recovery following Stroke module is a comprehen- sive summary of current evidence-based recommenda- tions, focusing primarily on the management of people who have already had a moderately or severely dis- abling stroke. People with milder stroke or transient ischemic attack may not require (...) for select patients with acute stroke (for instance, people with more mild strokesor transient ischemic attack) butcautionisadvised, andclinical judgmentshouldbeused(Evidence Level C). (iv) Once deemed to be medically and neurologically stable, patients should receive a recommended three hours perdayof directtask-specific therapy, five days aweek, delivered by the interdisciplinary stroke team (Evidence Level C); more therapy results in better outcomes (Evidence Level A). (v) Individualized

2020 CPG Infobase

12. The impact of a patient-directed activity program on functional outcomes and activity participation after stroke during inpatient rehabilitation-a randomized controlled trial (Abstract)

The impact of a patient-directed activity program on functional outcomes and activity participation after stroke during inpatient rehabilitation-a randomized controlled trial Individuals post stroke are inactive, even during rehabilitation, contributing to ongoing disability and risk of secondary health conditions. Our aims were to (1) conduct a randomized controlled trial to examine the efficacy of a "Patient-Directed Activity Program" on functional outcomes in people post stroke during (...) inpatient rehabilitation and (2) examine differences three months post inpatient rehabilitation discharge.Randomized control trial.Inpatient rehabilitation facility.Patients admitted to inpatient rehabilitation post stroke.Patient-Directed Activity Program (PDAP) or control (usual care only). Both groups underwent control (three hours of therapy/day), while PDAP participants were prescribed two additional 30-minute activity sessions/day.Outcomes (Stroke Rehabilitation Assessment of Movement Measure

2020 EvidenceUpdates

13. The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial (Abstract)

random code with an interactive web response system with stratification by site. Participants, investigators, the trial leadership, and all other personnel were masked to treatment allocation until the trial was completed and the database was locked. During the treatment period, participants in both groups were instructed to inject study drug on the same day at around the same time, each week. Strokes were categorised as fatal or non-fatal, and as either ischaemic, haemorrhagic, or undetermined (...) . Stroke severity was assessed using the modified Rankin scale. Participants were seen at 2 weeks, 3 months, 6 months, and then every 3 months for drug dispensing and every 6 months for detailed assessments, until 1200 confirmed primary outcomes accrued. The primary endpoint was the first occurrence of any component of the composite outcome, which comprised non-fatal myocardial infarction, non-fatal stroke, or death from cardiovascular or unknown causes. All analyses were done according to an intention

2020 EvidenceUpdates

14. Patent foramen ovale (PFO) closure in patients with cryptogenic ischaemic stroke

compared with women: odds ratio (OR) 1.50, 95% confidence interval (CI) 1.08 to 2.08, p=0.015 7 . SHTG Advice | 10 In a large population-based cohort study in Oxfordshire (OXVASC), consecutive patients with a first transient ischaemic attack (TIA) or ischaemic stroke were followed up for a period of 10 years 14 . Of 2,555 patients with a first ischaemic event, 32% were classed as cryptogenic. Incidence of cryptogenic ischaemic stroke in the OXVASC cohort was 0.36 per 1,000 population per year (95% CI (...) stroke or TIA has been indicated on clinical assessment and brain imaging. ? There is no significant atrial fibrillation requiring oral anticoagulant therapy. ? A full investigation has failed to identify known risk factors/explanations for the ischaemic stroke or TIA, such as vascular disease or hypertension. ? The presence of a PFO with a clinically significant right-to-left shunt or atrial septal aneurysm has been confirmed using bubble contrast transthoracic echocardiography, including

2020 SHTG Advice Statements

15. Heart Disease and Stroke Statistics—2020 Update Full Text available with Trip Pro

Heart Disease and Stroke Statistics—2020 Update Heart Disease and Stroke Statistics—2020 Update | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search February 2020 January 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Heart Disease and Stroke Statistics—2020 Update A Report From the American Heart Association , MD, PhD, FAHA (...) , annually reports on the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, congenital heart disease, rhythm disorders, subclinical

2020 American Heart Association

16. Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association Full Text available with Trip Pro

Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search February 2020 January 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump (...) to Free Access article Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association , MD, FAHA, Chair , MD, Co-Chair , MD, MPH, DrPH , , MD, MBA , MD, MPH, MSEd , JD, LLM , MPH , MD, MPH MD, MPH Robert A. Harrington , Robert M. Califf , Appathurai Balamurugan , Nancy Brown , Regina M. Benjamin , Wendy E. Braund , Janie Hipp , Madeleine Konig , Eduardo Sanchez , Karen E. Joynt Maddox Originally published 10 Feb 2020 Circulation. ;0:CIR

2020 American Heart Association

17. Effect of Additional Rehabilitation After Botulin Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial Full Text available with Trip Pro

Effect of Additional Rehabilitation After Botulin Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily (...) : Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Stroke Actions , 51 (2), 556-562 Feb 2020 Effect of Additional Rehabilitation After Botulinum Toxin-A on Upper Limb Activity in Chronic Stroke: The InTENSE Trial , , , , , , , , , , Collaborators, Affiliations Expand Collaborators InTENSE Trial Group

2020 EvidenceUpdates

18. Clinical frailty independently predicts early mortality after ischaemic stroke

Clinical frailty independently predicts early mortality after ischaemic stroke Clinical Frailty Independently Predicts Early Mortality After Ischaemic Stroke - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National Library of Medicine National (...) Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Age Ageing Actions 2020 Jan 17 [Online ahead of print] Clinical Frailty Independently Predicts Early Mortality After Ischaemic Stroke , , , , , Affiliations Expand Affiliations 1 Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. 2 Department of Medicine, University of Cambridge, Cambridge, UK. 3 Department of Medicine for the Elderly, Addenbrooke's Hospital

2020 EvidenceUpdates

19. Unilateral vs Bilateral Hybrid Approaches for Upper Limb Rehabilitation in Chronic Stroke: A Randomized Controlled Trial (Abstract)

Unilateral vs Bilateral Hybrid Approaches for Upper Limb Rehabilitation in Chronic Stroke: A Randomized Controlled Trial To investigate the effects of unilateral hybrid therapy (UHT) and bilateral hybrid therapy (BHT) compared with robot-assisted therapy (RT) alone in patients with chronic stroke.A single-blind, randomized controlled trial.Four hospitals.Outpatients with chronic stroke and mild to moderate motor impairment (N=44).UHT combined unilateral RT (URT) and modified constraint-induced (...) therapy. BHT combined bilateral RT (BRT) and bilateral arm training. The RT group received URT and BRT. The intervention frequency for the 3 groups was 90 min/d 3 d/wk for 6 weeks.Fugl-Meyer Assessment (FMA, divided into the proximal and distal subscale) and Stroke Impact Scale (SIS) version 3.0 scores before, immediately after, and 3 months after treatment and Wolf Motor Function Test (WMFT) and Nottingham Extended Activities of Daily Living (NEADL) scale scores before and immediately after

2020 EvidenceUpdates

20. Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window

Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health U.S. National (...) Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Neurology Actions 2019 Dec 31 [Online ahead of print] Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window , , , , , , , , , , Affiliations Expand Affiliations 1 From the Second Department of Neurology (G.T., A.H.K.), "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens

2020 EvidenceUpdates